Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13

Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence

Total article views   HTML views PDF downloads Totals
8,052 Dovepress* 5,710+ 999 6,709
PubMed Central* 2,342 539 2,881
Totals 8,052 1,538 9,590
*Since 27 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar